Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (281-290 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|June 28, 2017
Immunotherapy: PD-1 blockade exploiting MMR deficiencyDavid Killock
Nature Reviews. Clinical Oncology|April 8, 2021
Engaging results with glofitamabDavid Killock
Nature Reviews. Clinical Oncology|March 11, 2015
Haematological cancer: BCL-ABL1 resistance mutation--breakthrough with axitinibDavid Killock
Nature Reviews. Clinical Oncology|March 11, 2015
CNS cancer: Visualizing secrets of gliomaDavid Killock
Nature Reviews. Clinical Oncology|April 21, 2021
Copanlisib safe and active in combinationDavid Killock
Nature Reviews. Clinical Oncology|February 18, 2015
Targeted therapies: DNA polymerase θ-a new target for synthetic lethality?David Killock
Nature Reviews. Urology|June 18, 2014
Prostate cancer: viral gene therapy can improve IMRTDavid Killock
Nature Reviews. Clinical Oncology|September 30, 2024
From the ESMO Congress 2024David Killock
Nature Reviews. Clinical Oncology|March 25, 2015
Immunotherapy: Combined immunoradiotherapy reinvigorates antitumour immunityDavid Killock
Nature Reviews. Clinical Oncology|August 23, 2022
ARROW: pralsetinib hits target across cancersDavid Killock
Pageof 31

Showing results (281-290 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|June 28, 2017
Immunotherapy: PD-1 blockade exploiting MMR deficiencyDavid Killock
Nature Reviews. Clinical Oncology|April 8, 2021
Engaging results with glofitamabDavid Killock
Nature Reviews. Clinical Oncology|March 11, 2015
Haematological cancer: BCL-ABL1 resistance mutation--breakthrough with axitinibDavid Killock
Nature Reviews. Clinical Oncology|March 11, 2015
CNS cancer: Visualizing secrets of gliomaDavid Killock
Nature Reviews. Clinical Oncology|April 21, 2021
Copanlisib safe and active in combinationDavid Killock
Nature Reviews. Clinical Oncology|February 18, 2015
Targeted therapies: DNA polymerase θ-a new target for synthetic lethality?David Killock
Nature Reviews. Urology|June 18, 2014
Prostate cancer: viral gene therapy can improve IMRTDavid Killock
Nature Reviews. Clinical Oncology|September 30, 2024
From the ESMO Congress 2024David Killock
Nature Reviews. Clinical Oncology|March 25, 2015
Immunotherapy: Combined immunoradiotherapy reinvigorates antitumour immunityDavid Killock
Nature Reviews. Clinical Oncology|August 23, 2022
ARROW: pralsetinib hits target across cancersDavid Killock
Pageof 31